Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nimotuzumab and Radiotherapy
DRUG
2 trials
Sponsors
Peking University
, Peking University First Hospital
Conditions
Bladder (Urothelial, Transitional Cell) Cancer
SCCHN
Phase 1
An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer
Not yet recruiting
NCT07053735
Peking University First Hospital
Bladder (Urothelial, Transitional Cell) Cancer
Start: 2025-06-30
End: 2027-06-30
Target: 30
Updated: 2025-07-08
Phase 2
Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN
NCT01393184
Peking University
SCCHN
Start: 2011-03-31
End: 2013-03-31
Target: 92
Updated: 2011-07-13